Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy

Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy

Background: Spinal and bulbar muscular atrophy (SBMA) or Kennedy disease [OMIM: 313200] is a rare X-linked neuromuscular disease. Patients commonly present with muscle cramps, tremors, leg weakness, dysarthria and dysphagia.Methods: We deeply phenotyped and evaluated the possible extent of affected...

Bibliografiset tiedot
Päätekijät:	Elina Millere, Dmitrijs Rots, Ieva Glazere, Gita Taurina, Natalja Kurjane, Viktorija Priedite, Linda Gailite, Kaj Blennow, Henrik Zetterberg, Viktorija Kenina
Aineistotyyppi:	Artikkeli
Kieli:	English
Julkaistu:	Frontiers Media S.A. 2021-01-01
Sarja:	Frontiers in Neurology
Aiheet:	Kennedy disease spinal and bulbar muscular atrophy phenotype clinical features biomarker neurofilament
Linkit:	https://www.frontiersin.org/articles/10.3389/fneur.2020.586610/full

Samankaltaisia teoksia

Polyneuropathy in systemic sclerosis: exploring the causes and biomarkers
Tekijä: Kristīne Ivanova, et al.
Julkaistu: (2024-08-01)

Evaluating plasma biomarkers NfL, GFAP, GDF15, and FGF21 as indicators of disease severity in Charcot–Marie Tooth patients
Tekijä: Dace Pretkalnina, et al.
Julkaistu: (2025-01-01)

Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis
Tekijä: Igal Rosenstein, et al.
Julkaistu: (2022-08-01)

Editorial: Blood Biomarkers of Neurodegenerative Diseases
Tekijä: Thomas K. Karikari, et al.
Julkaistu: (2022-06-01)

Clinical stage and plasma neurofilament concentration in adults with Friedreich ataxia
Tekijä: Magnus Johnsson, et al.
Julkaistu: (2024-01-01)

GJB1 Gene Analysis in Two Extended Families with X-Linked Charcot-Marie-Tooth Disease
Tekijä: Sabine Kovale, et al.
Julkaistu: (2021-06-01)

Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre‐analytical conditions
Tekijä: Joel Simrén, et al.
Julkaistu: (2021-01-01)

Neurological involvement among non-hospitalized adolescents and young adults 6 months after acute COVID-19
Tekijä: Lise Beier Havdal, et al.
Julkaistu: (2024-02-01)

Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults
Tekijä: Grant L. Iverson, et al.
Julkaistu: (2022-11-01)

The role of ubiquitination in spinal and bulbar muscular atrophy
Tekijä: Medha Sengupta, et al.
Julkaistu: (2022-10-01)

Moving fluid biomarkers for Alzheimer’s disease from research tools to routine clinical diagnostics
Tekijä: Henrik Zetterberg, et al.
Julkaistu: (2021-02-01)

High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis
Tekijä: Igal Rosenstein, et al.
Julkaistu: (2023-01-01)

Functional and Cognitive Impairment in Patients with Relapsing–Remitting Multiple Sclerosis: Cognitive Tests and Plasma Neurofilament Light Chain Levels
Tekijä: Elina Polunosika, et al.
Julkaistu: (2025-01-01)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
Tekijä: Helena Sophia Gleerup, et al.
Julkaistu: (2021-05-01)

Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults
Tekijä: Lise Beier Havdal, et al.
Julkaistu: (2022-06-01)

Perioperative brain injury marker concentrations in neonatal open-heart surgery: a prospective observational study
Tekijä: Åsa Jungner, et al.
Julkaistu: (2023-08-01)

Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version
Tekijä: Arta Grosmane, et al.
Julkaistu: (2024-05-01)

Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study
Tekijä: Anja Fernqvist, et al.
Julkaistu: (2023-05-01)

The Cerebrospinal Fluid in Multiple Sclerosis
Tekijä: Florian Deisenhammer, et al.
Julkaistu: (2019-04-01)

Clinical Symptoms Influencing Parkinson’s Patients’ Quality of Life in Latvia: A Single-Center Cohort Study
Tekijä: Olga Minibajeva, et al.
Julkaistu: (2023-05-01)

Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer’s Disease
Tekijä: Tina E. Brinkley, et al.
Julkaistu: (2022-06-01)

Spinal and bulbar muscular atrophy with pseudomyotonia phenomena: a clinical case report
Tekijä: S. S. Nikitin, et al.
Julkaistu: (2020-01-01)

Spinal and Bulbar Muscular Atrophy – Genetic Causes, Clinical Presentation and Treatment Perspectives
Tekijä: Sara Emerla, et al.
Julkaistu: (2024-06-01)

Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders
Tekijä: Ulf Andreasson, et al.
Julkaistu: (2016-01-01)

The most common European HINT1 neuropathy variant phenotype and its case studies
Tekijä: Marija Rozevska, et al.
Julkaistu: (2023-02-01)

Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection
Tekijä: Linn Hermansson, et al.
Julkaistu: (2019-01-01)

Spitting image: can saliva biomarkers reflect Alzheimer's disease?
Tekijä: Nicholas J. Ashton, et al.
Julkaistu: (2021-06-01)

Neurofilament light chain on intensive care admission is an independent predictor of mortality in COVID-19: a prospective multicenter study
Tekijä: Theodor Sievert, et al.
Julkaistu: (2023-09-01)

Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration
Tekijä: Alberto Benussi, et al.
Julkaistu: (2022-10-01)

Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Tekijä: Christopher Clark, et al.
Julkaistu: (2021-03-01)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
Tekijä: Piotr Lewczuk, et al.
Julkaistu: (2018-07-01)

A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis
Tekijä: Sofia Sandgren, et al.
Julkaistu: (2023-09-01)

Tremor in X-linked recessive spinal and bulbar muscular atrophy (Kennedy's disease)
Tekijä: Francisco A. Dias, et al.
Julkaistu: (2011-01-01)

Spinal and bulbar muscular atrophy (Kennedy’s disease): case description
Tekijä: A. V. Gavrichenko, et al.
Julkaistu: (2020-02-01)

Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer’s disease
Tekijä: Peter Parbo, et al.
Julkaistu: (2020-01-01)

Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage
Tekijä: Lovisa Tobieson, et al.
Julkaistu: (2021-08-01)

Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy
Tekijä: Jamila Adra, et al.
Julkaistu: (2024-08-01)

Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease
Tekijä: Inga Zerr, et al.
Julkaistu: (2021-04-01)

Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Tekijä: Deborah O. T. Alawode, et al.
Julkaistu: (2022-04-01)

Prodromal frontotemporal dementia: clinical features and predictors of progression
Tekijä: Alberto Benussi, et al.
Julkaistu: (2021-11-01)